{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T23:45:53Z","timestamp":1775605553468,"version":"3.50.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ejso.2026.111409","type":"journal-article","created":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T16:21:38Z","timestamp":1768926098000},"page":"111409","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Enhanced Recovery After Surgery linked to lower CRS-HIPEC costs: micro-costing analysis in a European public hospital"],"prefix":"10.1016","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9999-1710","authenticated-orcid":false,"given":"Carlos","family":"Gonz\u00e1lez de Pedro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7061-345X","authenticated-orcid":false,"given":"Daniel","family":"Aparicio S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9964-1769","authenticated-orcid":false,"given":"Miriam","family":"\u00c1lvarez Aguilera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2616-9384","authenticated-orcid":false,"given":"Jaime","family":"Alonso G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Tinoco","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fco Javier","family":"Padillo Ruiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2422-5098","authenticated-orcid":false,"given":"Daniel","family":"D\u00edaz G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"20","key":"10.1016\/j.ejso.2026.111409_bib1","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1200\/JCO.2003.04.187","article-title":"Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer","volume":"21","author":"Verwaal","year":"2003","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2026.111409_bib2","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.annonc.2022.10.003","article-title":"Metastatic colorectal cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up","volume":"34","author":"Cervantes","year":"2023","journal-title":"Ann Oncol"},{"issue":"7","key":"10.1016\/j.ejso.2026.111409_bib3","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.ejso.2015.03.231","article-title":"Complete versus incomplete cytoreduction in peritoneal carcinosis from gastric cancer, with consideration to PCI cut-off. Systematic review and meta-analysis","volume":"41","author":"Coccolini","year":"2015","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2026.111409_bib4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejso.2020.02.012","article-title":"Appendiceal tumours and pseudomyxoma peritonei: literature review with PSOGI\/EURACAN clinical practice guidelines for diagnosis and treatment","volume":"47","author":"Govaerts","year":"2021","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2026.111409_bib5","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1056\/NEJMoa1708618","article-title":"Hyperthermic intraperitoneal chemotherapy in ovarian cancer","volume":"378","author":"van Driel","year":"2018","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.ejso.2026.111409_bib6","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1245\/s10434-021-11087-7","article-title":"Cytoreductive surgery with or without HIPEC after neoadjuvant chemotherapy in ovarian cancer: a phase 3 clinical trial","volume":"29","author":"Antonio","year":"2022","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2026.111409_bib7","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1001\/jamasurg.2022.0143","article-title":"Survival after hyperthermic intraperitoneal chemotherapy and primary or interval cytoreductive surgery in ovarian cancer: a randomized clinical trial","volume":"157","author":"Lim","year":"2022","journal-title":"JAMA Surg"},{"issue":"5","key":"10.1016\/j.ejso.2026.111409_bib8","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1245\/s10434-014-4157-9","article-title":"Cytoreductive surgery and HIPEC in recurrent epithelial ovarian cancer: a prospective randomized phase III study","volume":"22","author":"Spiliotis","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"10.1016\/j.ejso.2026.111409_bib9","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/S1470-2045(24)00531-X","article-title":"Hyperthermic intraperitoneal chemotherapy for recurrent ovarian cancer (CHIPOR): a randomised, open-label, phase 3 trial","volume":"25","author":"Classe","year":"2024","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2026.111409_bib10","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ejso.2020.02.011","article-title":"Peritoneal mesothelioma: PSOGI\/EURACAN clinical practice guidelines for diagnosis, treatment and follow-up","volume":"47","author":"Kusamura","year":"2021","journal-title":"Eur J Surg Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2026.111409_bib11","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1080\/02656736.2017.1367846","article-title":"Ninety-day post-operative morbidity and mortality using the national cancer Institute's common terminology criteria for adverse events better describe post-operative outcome after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"34","author":"Alyami","year":"2018","journal-title":"Int J Hyperther"},{"issue":"5","key":"10.1016\/j.ejso.2026.111409_bib12","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1245\/s10434-014-4025-7","article-title":"Association between hospital finances, payer mix, and complications after hyperthermic intraperitoneal chemotherapy: deficiencies in the current healthcare reimbursement system and future implications","volume":"22","author":"Squires","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2026.111409_bib13","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1245\/s10434-023-14442-y","article-title":"Cost analysis and financial implications of a peritoneal surface malignancy program in the USA","volume":"31","author":"Abreu","year":"2024","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2026.111409_bib14","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/SLA.0b013e3181c9b53c","article-title":"Evaluation of the cost-effectiveness of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (peritonectomy) at the st george hospital peritoneal surface malignancy program","volume":"251","author":"Chua","year":"2010","journal-title":"Ann Surg"},{"issue":"9","key":"10.1016\/j.ejso.2026.111409_bib15","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.anchir.2005.05.013","article-title":"Co\u00fbts et financement de la chimiohyperthermie intrap\u00e9 riton\u00e9ale (CHIP) associ\u00e9e \u00e0 une chirurgie d\u2019ex\u00e9r\u00e8se","volume":"130","author":"Bonastre","year":"2005","journal-title":"Ann Chir"},{"issue":"11","key":"10.1016\/j.ejso.2026.111409_bib16","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1007\/s00104-010-1927-1","article-title":"Hypertherme intraperitoneale Chemotherapie im G-DRG-System: Analyse der Fallkostenkalkulationen eines universit\u00e4ren Maximalversorgers","volume":"81","author":"Kilian","year":"2010","journal-title":"Chirurg"},{"issue":"5","key":"10.1016\/j.ejso.2026.111409_bib17","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ejso.2010.03.005","article-title":"Cost analysis of the combined procedure of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC)","volume":"36","author":"Baratti","year":"2010","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2026.111409_bib18","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.ejso.2014.12.004","article-title":"Peritonectomy and hyperthermic intraperitoneal chemotherapy: cost analysis and sustainability","volume":"41","author":"Bagnoli","year":"2015","journal-title":"Eur J Surg Oncol"},{"issue":"9","key":"10.1016\/j.ejso.2026.111409_bib19","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.anchir.2005.05.013","article-title":"Co\u00fbts et financement de la chimiohyperthermie intrap\u00e9 riton\u00e9ale (CHIP) associ\u00e9e \u00e0 une chirurgie d\u2019ex\u00e9r\u00e8se","volume":"130","author":"Bonastre","year":"2005","journal-title":"Ann Chir"},{"issue":"1","key":"10.1016\/j.ejso.2026.111409_bib20","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1515\/pp-2022-0133","article-title":"Implementation of an enhanced recovery program for complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a referral center: a case control prospective study","volume":"8","author":"Charleux-Muller","year":"2023","journal-title":"Pleura Peritoneum"},{"issue":"2","key":"10.1016\/j.ejso.2026.111409_bib21","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1515\/pp-2022-0198","article-title":"Enhanced recovery after surgery in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: national survey of peri-operative practice by Indian society of peritoneal surface malignancies","volume":"8","author":"Somashekhar","year":"2023","journal-title":"Pleura Peritoneum"},{"issue":"13","key":"10.1016\/j.ejso.2026.111409_bib22","doi-asserted-by":"crossref","first-page":"8156","DOI":"10.1245\/s10434-023-14222-8","article-title":"Impact of successful implementation of an enhanced recovery after surgery protocol for patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"30","author":"Sun","year":"2023","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2026.111409_bib23","article-title":"Improved postoperative pain management outcomes after implementation of Enhanced Recovery After Surgery (ERAS) protocol for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC)","volume":"31","author":"Yue","year":"2024","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2026.111409_bib24","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.mei.2015.06.001","article-title":"Estructura, sistemas y an\u00e1lisis de costos de la atenci\u00f3n m\u00e9dica hospitalaria","volume":"3","author":"Santamar\u00eda Benhumea","year":"2015","journal-title":"Medicina e Investigaci\u00f3n"},{"key":"10.1016\/j.ejso.2026.111409_bib25","doi-asserted-by":"crossref","DOI":"10.1186\/1472-6963-11-128","article-title":"Basing care reforms on evidence: the Kenya health sector costing model","volume":"11","author":"Flessa","year":"2011","journal-title":"BMC Health Serv Res"},{"issue":"2","key":"10.1016\/j.ejso.2026.111409_bib26","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/heapol\/czh015","article-title":"Cost and unit cost calculations using step-down accounting","volume":"19","author":"Conteh","year":"2004","journal-title":"Health Pol Plann"},{"issue":"10","key":"10.1016\/j.ejso.2026.111409_bib27","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1002\/hec.1422","article-title":"Equivalence of two healthcare costing methods: bottom-up and top-down","volume":"18","author":"Chapko","year":"2009","journal-title":"Health Econ"},{"issue":"1","key":"10.1016\/j.ejso.2026.111409_bib28","doi-asserted-by":"crossref","DOI":"10.3402\/gha.v7.23257","article-title":"Collecting and analysing cost data for complex public health trials: reflections on practice","volume":"7","author":"Batura","year":"2014","journal-title":"Glob Health Action"},{"key":"10.1016\/j.ejso.2026.111409_bib29","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/hec.3295","article-title":"Using top-down and Bottom-up costing approaches in LMICs: the case for using both to assess the incremental costs of new technologies at scale","volume":"25","author":"Cunnama","year":"2016","journal-title":"Health Econ"},{"issue":"1","key":"10.1016\/j.ejso.2026.111409_bib30","doi-asserted-by":"crossref","DOI":"10.3402\/gha.v7.23573","article-title":"Step-by-step guideline for disease-specific costing studies in low- and middle-income countries: a mixed methodology","volume":"7","author":"Hendriks","year":"2014","journal-title":"Glob Health Action"},{"key":"10.1016\/j.ejso.2026.111409_bib31","article-title":"The 2022 PSOGI international consensus on HIPEC regimens for peritoneal malignancies: epithelial ovarian cancer","volume":"30","author":"Bhatt","year":"2023","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2026.111409_bib32","series-title":"Cytoreductive surgery & perioperative chemotherapy for peritoneal surface malignancy TEXTBOOK AND VIDEO ATLAS","first-page":"17","article-title":"An overview of peritonectomy, visceral resection, and therapeutic laparoscopy for peritoneal surface malignancy","author":"Sugarbaker K van der S","year":"2017"},{"key":"10.1016\/j.ejso.2026.111409_bib33","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2026.111409_bib34","series-title":"por la que se modifica la Orden de 14 de octubre de 2005, por la que se fijan los precios p\u00fablicos de los servicios sanitarios prestados por centros dependientes del Sistema Sanitario P\u00fablico de Andaluc\u00eda","year":"2015"},{"key":"10.1016\/j.ejso.2026.111409_bib35","series-title":"Estimaci\u00f3n de pesos y costes de los procesos hospitalarios en el Sistema Nacional de Salud: metodolog\u00eda y principales resultados. Proyecto 2017","first-page":"1","year":"2019"},{"issue":"9","key":"10.1016\/j.ejso.2026.111409_bib36","doi-asserted-by":"crossref","first-page":"5265","DOI":"10.1245\/s10434-020-09476-5","article-title":"Impact of enhanced recovery after surgery on postoperative outcomes for patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"28","author":"White","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2026.111409_bib37","doi-asserted-by":"crossref","first-page":"331","DOI":"10.5455\/medarh.2019.73.331-337","article-title":"Evaluation of enhanced recovery after following a surgical protocol for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis","volume":"73","author":"Duzgun","year":"2019","journal-title":"Med Arch"},{"issue":"13","key":"10.1016\/j.ejso.2026.111409_bib38","doi-asserted-by":"crossref","first-page":"8156","DOI":"10.1245\/s10434-023-14222-8","article-title":"Impact of successful implementation of an enhanced recovery after surgery protocol for patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"30","author":"Sun","year":"2023","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2026.111409_bib39","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ejso.2010.03.005","article-title":"Cost analysis of the combined procedure of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC)","volume":"36","author":"Baratti","year":"2010","journal-title":"Eur J Surg Oncol"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798326000284?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798326000284?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T22:51:29Z","timestamp":1775602289000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798326000284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0748798326000284"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2026.111409","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhanced Recovery After Surgery linked to lower CRS-HIPEC costs: micro-costing analysis in a European public hospital","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2026.111409","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111409"}}